Biopharma needs to radically improve the speed with which it innovates and to deliver differentiated medicines that provide more value, backed by real world evidence. Is artificial intelligence just the latest buzzword or is it a real panacea to the industry’s ills?

Ability Level: Intermediate

Session ID: 21262